CovidChloroV1, Main, Corpus, bibRecord, 000B03

Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.

Identifieur interne : 000B03 ( Main/Corpus ); précédent : 000B02; suivant : 000B04

Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.

Auteurs : Souraya Domiati ; Mohamad Itani ; Ghida Itani

Source :

Frontiers in medicine [ 2296-858X ] ; 2020.

RBID : pubmed:33015096

Abstract

Objectives: Distinct measures were adopted in Lebanon to prohibit the spreading of SARS-CoV-2. These actions provide positive results only if the population chooses to be compliant. Aim: Accordingly, this study aimed to reflect the Lebanese population adherence by determining their level of knowledge and practice during this pandemic. Method: A cross-sectional online survey was performed in April 2020. It involved 410 volunteers from the main 5 Lebanese districts. The questionnaire was divided into 3 parts; sociodemographic, knowledge, and practice. A score was calculated out of 18 points to evaluate the knowledge of the respondents. The last 8 questions reflected the participants' precautionary methods during the pandemic. Descriptive statistics and one-way analysis of variance tests were conducted using SPSS version 20. Results: The overall correct rate of the knowledge questionnaire was 75%. Survey completers of extreme age groups (under 18 and >44), elementary education level, and medical occupation displayed the least level of knowledge compared to other groups (p < 0.05). Most of the participants showed proactive practices to protect themselves against COVID-19. They covered their mouths (81.2%), threw the used tissues (93.7%), and washed their hands (66.6%) after sneezing or coughing. Moreover, they wore face masks if they were sick (59%) or in a crowded place (79.3%). Concerning Hydroxychloroquine, 10% claimed that they would take it if they have COVID-19 symptoms. Conclusion: This survey sheds the light on the fact that one mandatory measure does not fit all the population; there must be a specialized method of prevention for each profession, age group, and area of the country to prevent the outbreak of COVID-19.

DOI: 10.3389/fmed.2020.00542
PubMed: 33015096
PubMed Central: PMC7461812

Links to Exploration step

pubmed:33015096

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.</title>
<author><name sortKey="Domiati, Souraya" sort="Domiati, Souraya" uniqKey="Domiati S" first="Souraya" last="Domiati">Souraya Domiati</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Itani, Mohamad" sort="Itani, Mohamad" uniqKey="Itani M" first="Mohamad" last="Itani">Mohamad Itani</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Itani, Ghida" sort="Itani, Ghida" uniqKey="Itani G" first="Ghida" last="Itani">Ghida Itani</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33015096</idno>
<idno type="pmid">33015096</idno>
<idno type="doi">10.3389/fmed.2020.00542</idno>
<idno type="pmc">PMC7461812</idno>
<idno type="wicri:Area/Main/Corpus">000B03</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B03</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.</title>
<author><name sortKey="Domiati, Souraya" sort="Domiati, Souraya" uniqKey="Domiati S" first="Souraya" last="Domiati">Souraya Domiati</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Itani, Mohamad" sort="Itani, Mohamad" uniqKey="Itani M" first="Mohamad" last="Itani">Mohamad Itani</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Itani, Ghida" sort="Itani, Ghida" uniqKey="Itani G" first="Ghida" last="Itani">Ghida Itani</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Frontiers in medicine</title>
<idno type="ISSN">2296-858X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><b>Objectives:</b>
 Distinct measures were adopted in Lebanon to prohibit the spreading of SARS-CoV-2. These actions provide positive results only if the population chooses to be compliant. <b>Aim:</b>
 Accordingly, this study aimed to reflect the Lebanese population adherence by determining their level of knowledge and practice during this pandemic. <b>Method:</b>
 A cross-sectional online survey was performed in April 2020. It involved 410 volunteers from the main 5 Lebanese districts. The questionnaire was divided into 3 parts; sociodemographic, knowledge, and practice. A score was calculated out of 18 points to evaluate the knowledge of the respondents. The last 8 questions reflected the participants' precautionary methods during the pandemic. Descriptive statistics and one-way analysis of variance tests were conducted using SPSS version 20. <b>Results:</b>
 The overall correct rate of the knowledge questionnaire was 75%. Survey completers of extreme age groups (under 18 and >44), elementary education level, and medical occupation displayed the least level of knowledge compared to other groups (<i>p</i>
 < 0.05). Most of the participants showed proactive practices to protect themselves against COVID-19. They covered their mouths (81.2%), threw the used tissues (93.7%), and washed their hands (66.6%) after sneezing or coughing. Moreover, they wore face masks if they were sick (59%) or in a crowded place (79.3%). Concerning Hydroxychloroquine, 10% claimed that they would take it if they have COVID-19 symptoms. <b>Conclusion:</b>
 This survey sheds the light on the fact that one mandatory measure does not fit all the population; there must be a specialized method of prevention for each profession, age group, and area of the country to prevent the outbreak of COVID-19.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33015096</PMID>
<DateRevised><Year>2020</Year>
<Month>10</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>7</Volume>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in medicine</Title>
<ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation>
</Journal>
<ArticleTitle>Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>542</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2020.00542</ELocationID>
<Abstract><AbstractText><b>Objectives:</b>
 Distinct measures were adopted in Lebanon to prohibit the spreading of SARS-CoV-2. These actions provide positive results only if the population chooses to be compliant. <b>Aim:</b>
 Accordingly, this study aimed to reflect the Lebanese population adherence by determining their level of knowledge and practice during this pandemic. <b>Method:</b>
 A cross-sectional online survey was performed in April 2020. It involved 410 volunteers from the main 5 Lebanese districts. The questionnaire was divided into 3 parts; sociodemographic, knowledge, and practice. A score was calculated out of 18 points to evaluate the knowledge of the respondents. The last 8 questions reflected the participants' precautionary methods during the pandemic. Descriptive statistics and one-way analysis of variance tests were conducted using SPSS version 20. <b>Results:</b>
 The overall correct rate of the knowledge questionnaire was 75%. Survey completers of extreme age groups (under 18 and >44), elementary education level, and medical occupation displayed the least level of knowledge compared to other groups (<i>p</i>
 < 0.05). Most of the participants showed proactive practices to protect themselves against COVID-19. They covered their mouths (81.2%), threw the used tissues (93.7%), and washed their hands (66.6%) after sneezing or coughing. Moreover, they wore face masks if they were sick (59%) or in a crowded place (79.3%). Concerning Hydroxychloroquine, 10% claimed that they would take it if they have COVID-19 symptoms. <b>Conclusion:</b>
 This survey sheds the light on the fact that one mandatory measure does not fit all the population; there must be a specialized method of prevention for each profession, age group, and area of the country to prevent the outbreak of COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020 Domiati, Itani and Itani.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Domiati</LastName>
<ForeName>Souraya</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Itani</LastName>
<ForeName>Mohamad</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Itani</LastName>
<ForeName>Ghida</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Front Med (Lausanne)</MedlineTA>
<NlmUniqueID>101648047</NlmUniqueID>
<ISSNLinking>2296-858X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Lebanese</Keyword>
<Keyword MajorTopicYN="N">attitude</Keyword>
<Keyword MajorTopicYN="N">knowledge</Keyword>
<Keyword MajorTopicYN="N">pandemic</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>21</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33015096</ArticleId>
<ArticleId IdType="doi">10.3389/fmed.2020.00542</ArticleId>
<ArticleId IdType="pmc">PMC7461812</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nature. 2020 May;581(7808):247-248</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409766</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mil Med Res. 2020 Mar 13;7(1):11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32169119</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Apr 27;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32338708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hosp Infect. 2020 Jun;105(2):183-187</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32278701</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Community Health. 2020 Oct;45(5):881-890</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32318986</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hautarzt. 1991 Mar;42(3):140-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2055762</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Biol Sci. 2020 Mar 15;16(10):1686-1697</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32226286</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Jun;582(7813):469</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32546811</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Biol Sci. 2020 Mar 15;16(10):1745-1752</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32226294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JMIR Public Health Surveill. 2020 Apr 30;6(2):e19160</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32320381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Microbiol. 2017 Jan;25(1):35-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27743750</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Allergy. 2020 Jul;75(7):1742-1752</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32239761</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Rev Microbiol. 2020 Mar;46(2):182-193</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282268</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2020 May;94:119-124</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32247050</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Autoimmun. 2020 May;109:102433</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32113704</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Apr;580(7805):576-577</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32346146</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Asian J Psychiatr. 2020 Jun;51:102083</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32283510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2020 Jul;81(1):1-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32315723</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B03 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000B03 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33015096
   |texte=   Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33015096" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.

Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki